Pete has over 30 years of health care operating and venture capital experience. In addition to co-founding Thomas, McNerney & Partners, Pete co-founded Coral Ventures in 1992, where he was responsible for health care investing. Pete has served on the board of a number of the Coral Ventures' and Thomas, McNerney and Partners' portfolio companies. Prior to joining Coral in 1992, Pete was a co-founder and Managing Partner of The Kensington Group, a firm specializing in providing management services to early stage companies in the health care field. In 1986, he founded and was Chief Executive Officer of Memtec North America, a company established to commercialize cross flow membrane microfiltration technology in North America. Previously, Pete spent 11 years with Baxter Healthcare Corporation, where he held various general management positions in the U.S., Europe, Middle East and Southeast Asia. He has served as President of the Minnesota Venture Capital Association and is on the Board of Trustees of Blue Cross and Blue Shield of Minnesota. A Certified Public Accountant, Pete received a B.A. from Yale and an M.B.A. from Stanford University.  Pete was a 2014 fellow at Harvard's Advanced Leadership Initiative program.

• B.A., Yale University
• MBA, Stanford University

• Founder & Senior Advisor, Thomas, Mcnerney & Partners, 2001-present
• Partner, Coral Ventures, 1992-2001
• Partner, The Kensington Group, 1990-1992
• Chief Executive Officer, Memtec North America, 1986-1989
• Management, Baxter Healthcare, 1975-1986

Forging and Funding Healthcare Startups (HCAK-927-0)
The objective of the course is to educate students on the complex challenges of forging, building and investing in innovative early stage companies in the health care industry. The course will review the different segments within health care each with their own unique challenges; medical devices, health care services (including digital heath) and life sciences. Students will be introduced to early stage health care companies from each of the segments and learn first hand from the founder/CEO the challenges they face. Students will be placed on teams and each team will be tasked with deciding how to allocate investment capital among these and other companies. The objective is to provide each student with a first-hand appreciation of the obstacles faced by early stage health care companies and to give students an opportunity to make and defend decisions in the difficult world of early stage investing. Readings will include industry literature and company backgrounds. Guest speakers will include venture capitalists and the CEOs of early stage health care companies. Assignments will include investment memos, new business ideas and a final team report. Due to the COVID constraints and restrictions, HCAK 927 will be taught remotely.

NUVention: Medical Innovation II (HCAK-616-0)

**HCAK-615 is a two-quarter sequence course in conjunction with HCAK-616**

NUVention Medical is a two-term course designed to give students the experience of being an innovator and entrepreneur in the world of health care technology. Students form teams and each team conceives of or identifies an innovative new product or service and develops a prototype and a commercialization plan. Students from Feinberg, McCormick , Pritzker as well as Kellogg participate in the course with at least one student from each school on each team. In the fall term, student teams will explore unmet market needs, understand important market characteristics, conceive of an innovative product with a convincing value proposition, explore many of the challenges facing health care and “pitch” their idea. In the winter term, the teams will validate the customer and stakeholders and explore different revenue models, sales and distribution channels and sources of capital. Each team is required to develop a full investor presentation backed up by a business plan and a viable prototype. Both the fall pitch and final investor presentation will be made to a group of experienced health care executives and investors. After the fall term, students will be given the choice of whether or not to continue into the winter term and the faculty will decide which ideas are eligible to advance based on their business potential. All students with acceptable attendance and level of effort in the fall term will be permitted to continue whether their team’s idea advances or not, possibly necessitating some team modifications. Readings include text, industry articles and a few cases. Classes are held at the Law School, KGH, and the Ford design center. A number of classes will have guest speakers. Students are evaluated on the basis of both team and individual assignments with team assignments more heavily weighted. Grades will be awarded for each term separately. Permission from the student's school faculty representative is required to register. Students must complete the fall (I) quarter (HCAK 615) in order to be eligible for the winter (II) quarter (HCAK 616), and will earn 1.0 credit for each term completed. Students in the 2 Year Full Time program and the Evening & Weekend program must have completed one full year. Students in the 1 Year program need to have completed the summer quarter.

NUVention: Medical Innovation I (HCAK-615-0)

**HCAK-615 is a two-quarter sequence course in conjunction with HCAK-616**

NUvention Medical is a two-term course designed to give students the experience of being an innovator and entrepreneur in the world of health care technology. Students form teams and each team conceives of or identifies an innovative new product or service and develops a prototype and a commercialization plan. Students from Feinberg, McCormick , Pritzker as well as Kellogg participate in the course with at least one student from each school on each team. In the fall term, student teams will explore unmet market needs, understand important market characteristics, conceive of an innovative product with a convincing value proposition, explore many of the challenges facing health care and “pitch” their idea. In the winter term, the teams will validate the customer and stakeholders and explore different revenue models, sales and distribution channels and sources of capital. Each team is required to develop a full investor presentation backed up by a business plan and a viable prototype. Both the fall pitch and final investor presentation will be made to a group of experienced health care executives and investors. After the fall term, students will be given the choice of whether or not to continue into the winter term and the faculty will decide which ideas are eligible to advance based on their business potential. All students with acceptable attendance and level of effort in the fall term will be permitted to continue whether their team’s idea advances or not, possibly necessitating some team modifications. Readings include text, industry articles and a few cases. Classes are held at the Law School, KGH, and the Ford design center. A number of classes will have guest speakers. Students are evaluated on the basis of both team and individual assignments with team assignments more heavily weighted. Grades will be awarded for each term separately. Permission from the student's school faculty representative is required to register. Students must complete the fall (I) quarter (HCAK 615) in order to be eligible for the winter (II) quarter (HCAK 616), and will earn 1.0 credit for each term completed. Students in the 2 Year Full Time program and the Evening & Weekend program must have completed one full year. Students in the 1 Year program need to have completed the summer quarter. Due to the COVID constraints and restrictions, HCAK 615, the fall term, will be taught remotely.

Field Study (HCAK-498-0)
Field Studies include those opportunities outside of the regular curriculum in which a student is working with an outside company or non-profit organization to address a real-world business challenge for course credit under the oversight of a faculty member.